IL-15 aggravates atherosclerotic lesion development in LDL receptor deficient mice.

[1]  D. Vestweber,et al.  Vaccination against CD99 inhibits atherogenesis in low-density lipoprotein receptor-deficient mice. , 2008, Cardiovascular research.

[2]  T. Yajima,et al.  IL‐15 exacerbates collagen‐induced arthritis with an enhanced CD4+ T cell response to produce IL‐17 , 2007, European journal of immunology.

[3]  P. Quax,et al.  Vaccination Against VEGFR2 Attenuates Initiation and Progression of Atherosclerosis , 2007 .

[4]  P. Quax,et al.  Vaccination against VEGFR2 attenuates initiation and progression of atherosclerosis. , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[5]  P. Parren,et al.  Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study. , 2005, Arthritis and rheumatism.

[6]  J. Renauld,et al.  Blockade of Interleukin-12 Function by Protein Vaccination Attenuates Atherosclerosis , 2005, Circulation.

[7]  François Mach,et al.  Inflammation and Atherosclerosis , 2004, Herz.

[8]  J. Becker,et al.  A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth , 2002, Nature Network Boston.

[9]  T. Waldmann,et al.  IL-15Rα Recycles and Presents IL-15 In trans to Neighboring Cells , 2002 .

[10]  M. Kronenberg,et al.  Homeostasis of Vα14i NKT cells , 2002, Nature Immunology.

[11]  T. V. van Berkel,et al.  Targeting of peptides to restenotic vascular smooth muscle cells using phage display in vitro and in vivo. , 2002, Biochimica et biophysica acta.

[12]  Y. Li,et al.  IL-15 mimics T cell receptor crosslinking in the induction of cellular proliferation, gene expression, and cytotoxicity in CD8+ memory T cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[13]  P. Eriksson,et al.  Expression of interleukin-15 in mouse and human atherosclerotic lesions. , 2001, The American journal of pathology.

[14]  A. Moorman,et al.  Interleukin-15 Expression in Atherosclerotic Plaques: An Alternative Pathway for T-Cell Activation in Atherosclerosis? , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[15]  T. V. van Berkel,et al.  Induction of Rapid Atherogenesis by Perivascular Carotid Collar Placement in Apolipoprotein E–Deficient and Low-Density Lipoprotein Receptor–Deficient Mice , 2001, Circulation.

[16]  T. Waldmann,et al.  Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy. , 2001, Immunity.

[17]  P. Marrack,et al.  Control of homeostasis of CD8+ memory T cells by opposing cytokines. , 2000, Science.

[18]  M. Mohamadzadeh,et al.  Interleukin 15 Induces Endothelial Hyaluronan Expression in Vitro and Promotes Activated T Cell Extravasation through a Cd44-Dependent Pathway in Vivo , 1999, The Journal of experimental medicine.

[19]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[20]  M. Zucca,et al.  Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15. , 1999, Blood.

[21]  J. Sprent,et al.  Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. , 1998, Immunity.

[22]  L. Notarangelo,et al.  Interleukin-15 (IL-15) induces IL-8 and monocyte chemotactic protein 1 production in human monocytes , 1997 .

[23]  M. Fenton,et al.  IL-15 functions as a potent autocrine regulator of macrophage proinflammatory cytokine production: evidence for differential receptor subunit utilization associated with stimulation or inhibition. , 1997, Journal of immunology.

[24]  P. Allavena,et al.  IL‐15 is chemotactic for natural killer cells and stimulates their adhesion to vascular endothelium , 1997, Journal of leukocyte biology.

[25]  D. Cosman,et al.  IL‐15, a novel T cell growth factor that shares activities and receptor components with IL‐2 , 1995, Journal of leukocyte biology.

[26]  J. Witztum,et al.  T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[27]  G. Hansson,et al.  Immune mechanisms in atherosclerosis. , 1994, Coronary artery disease.

[28]  M. Cybulsky,et al.  Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. , 1991, Science.

[29]  B. Pamukcu,et al.  Influences of genetic variants in interleukin-15 gene and serum interleukin-15 levels on coronary heart disease. , 2010, Cytokine.

[30]  T. Waldmann,et al.  IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells. , 2002, Immunity.

[31]  M. Kronenberg,et al.  Homeostasis of V alpha 14i NKT cells. , 2002, Nature immunology.

[32]  P. Wilkinson,et al.  Locomotion and chemotaxis of lymphocytes. , 1997, Autoimmunity.